Does This Acquisition Make Pfizer Stock a Great Buy?

Remember Pfizer (NYSE: PFE), the giant pharmaceutical company that developed a COVID-19 vaccine within weeks of the pandemic hitting U.S. shores and got it approved within a year? It was the fastest vaccine development in history and a miracle of modern science. The company could clearly move quickly when it needed to do so.Pfizer's share price reflected that incredible success. It nearly tripled in price from March 2020 to December 2021. Needless to say, Pfizer shareholders were elated (as was just about everyone else who got the vaccine, to be perfectly honest).But as the pandemic continues to recede into the rearview mirror, investors have been asking of Pfizer, "What have you done for me lately?" Pfizer's latest move may help to answer that question.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool